CLEDUCATE.BO stock plunged 19.81% to INR 58.55 on the BSE at close on 09 Feb 2026, making it one of the session’s top losers. The sharp move followed recent earnings and left price sitting near the 52-week low of INR 58.41. Volume rose to 12,684.00 shares versus an average of 9,656.00, flagging outsized selling. Investors should weigh weak EPS and elevated leverage against a modest book value and cash per share before deciding a strategy.
Price action and liquidity for CLEDUCATE.BO stock
The main fact: CLEDUCATE.BO stock closed at INR 58.55, down 19.81% from the prior close of INR 73.01. The session range was INR 55.91–61.41, with the stock opening at INR 59.48.
Advertisement
Trading intensity rose: volume was 12,684.00 shares versus an average volume of 9,656.00, giving a relative volume of 9.43. That spike shows concentrated activity and lower intra-day liquidity at current prices on the BSE in India.
Earnings, fundamentals and what likely triggered the drop
CL Educate Limited reported weak recent metrics and an EPS of -1.34, leaving a negative PE of -44.70 and a net income pressure that likely underpinned the sell-off. The formal earnings announcement was recorded on 02 Feb 2026, and market reaction appears to have continued into this session.
Fundamentals show mixed support: cash per share is 50.33, book value per share is 50.46, and revenue per share TTM is 88.16. Balance-sheet ratios include a current ratio of 1.88 and debt to equity of 1.03, highlighting financial leverage that raises risk if margins stay weak.
Technical snapshot and short-term outlook for CLEDUCATE.BO stock
Short-term technicals are bearish but oversold. The RSI stands at 37.21, MACD is -0.57 with a histogram at -0.35, and the CCI reads -141.34, a clear oversold signal. Price sits well below the 50-day average of INR 81.06 and the 200-day average of INR 90.25, which confirms the downtrend.
Momentum indicators suggest a possible bounce if buyers re-enter near the INR 55.91 intra-day low. Traders should watch a sustained move above INR 70.00 and improving MACD signal as the first signs of trend repair.
Valuation vs sector: CLEDUCATE.BO stock relative value
On valuation, CL Educate shows a price-to-book ratio of 1.16 and a price-to-sales of 0.67, both materially lower than Consumer Defensive peers whose average PB is around 4.06. Enterprise value over EBITDA is 6.71, which can look attractive if earnings normalize.
However, return on equity is negative at -6.41% and net margins are below peers. The company’s leverage (debt to equity 1.03) and volatile earnings growth argue for a cautious valuation view despite low multiples.
Meyka AI grade and CLEDUCATE.BO stock forecast
Meyka AI rates CLEDUCATE.BO with a score out of 100: 69.92 / 100 (Grade B) and the platform suggestion is HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus.
Meyka AI’s forecast model projects a 12‑month target of INR 96.47, a three‑year level of INR 88.90, and short-term readings at INR 22.49 (monthly) and INR 38.28 (quarterly). Versus the current price of INR 58.55, the 12‑month model implies an upside of 64.79%. Forecasts are model-based projections and not guarantees.
Trading strategy, price targets and risks for CLEDUCATE.BO stock
For active traders, a tactical plan could be: watch for support at INR 55.00 and resistance near INR 70.00; a stop-loss below INR 50.00 limits downside on short trades. Suggested price targets: conservative INR 70.00, base INR 96.47, and stretch INR 120.00 if fundamentals improve.
Key risks include continued negative earnings, high receivables days (DSO 118.30) and debt servicing pressure with interest coverage around 2.40. Sector headwinds in Education & Training Services and low market liquidity can add volatility to any recovery attempt.
Final Thoughts
CLEDUCATE.BO stock closed the BSE session at INR 58.55 on 09 Feb 2026, down 19.81% after earnings and renewed selling pressure. The drop leaves the stock near its 52‑week floor and well under the 50‑ and 200‑day averages. Fundamentals show mixed signals: healthy cash per share (INR 50.33) and a book value near INR 50.46, but negative EPS (-1.34) and leverage (debt to equity 1.03) increase downside risk. Technically, oversold indicators open the door for a short-term bounce, but a convincing recovery needs volume-backed gains and a move above INR 70.00. Meyka AI’s model projects a 12‑month target of INR 96.47, implying a 64.79% upside from today’s close; this is a model projection, not a guarantee. Investors should balance the forecast against persistent earnings weakness and sector trends in the Education & Training Services industry. For those tracking this top loser, use tight risk controls and confirm any rebound with improving fundamentals and tradeable volume. For more company detail, see CL Educate’s site source and our Meyka stock page source. Meyka AI is an AI-powered market analysis platform that provides model-driven context to help frame decisions.
Advertisement
FAQs
Why did CLEDUCATE.BO stock fall so sharply on 09 Feb 2026?
The fall followed weak earnings metrics and investor selling after the 02 Feb 2026 earnings cycle. EPS is negative at -1.34 and leverage is high, prompting sharper downside on the BSE close at INR 58.55.
What are the near-term technical signals for CLEDUCATE.BO stock?
Short-term indicators are oversold: RSI 37.21, CCI -141.34, and MACD negative. Watch for a move above INR 70.00 and rising volume to confirm a trend reversal.
What price targets and forecasts exist for CLEDUCATE.BO stock?
Meyka AI’s 12-month forecast is INR 96.47, implying 64.79% upside from INR 58.55. Conservative near-term target is INR 70.00 and downside support sits near INR 55.00. Forecasts are not guarantees.
Is CLEDUCATE.BO stock a value play versus its sector?
On multiples, CLEDUCATE.BO looks cheaper with PB 1.16 and P/S 0.67, while the Consumer Defensive peer PB is about 4.06. Still, negative ROE and volatile earnings raise valuation risk.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
Advertisement
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)